Avicanna Announces Changes to its Board of Directors
TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. ("Avicanna" or "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products,
(Financial Post, 2025-12-23T12:30:36Z)